Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-03 Sale |
2025-03-05 4:22 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
2,755 | $242.94 | $669,304 | 21,857 (Indirect Direct) |
View |
| 2025-02-28 Sale |
2025-03-03 4:30 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
496 | $241.69 | $119,878 | 12,922 (Indirect Direct) |
View |
| 2025-02-14 Sale |
2025-02-18 4:47 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
2,103 | $252.71 | $531,448 | 13,418 (Indirect Direct) |
View |
| 2024-11-26 Sale |
2024-11-27 5:20 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
3,000 | $251.65 | $754,947 | 13,418 (Indirect Direct) |
View |
| 2024-08-12 Sale |
2024-08-14 4:12 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
22,025 | $270.99 | $5,968,516 | 15,610 (Indirect Direct) |
View |
| 2024-06-25 Sale |
2024-06-26 4:26 pm |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
1,198 | $230.99 | $276,731 | 14,718 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-03 Option Award |
2025-03-05 4:22 pm |
N/A 2035-03-03 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
11,690 | $0 | 21,857 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 4:47 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
2,103 | $0 | 13,418 (Direct) |
View |
| 2024-12-12 Option Award |
2024-12-16 4:15 pm |
N/A 2034-12-11 |
Ovid Therapeutics Inc. | OVID | Fitzgerald Kevin Joseph Director |
90,000 | $0 | 90,000 (Direct) |
View |
| 2024-11-25 Option Award |
2024-11-27 5:20 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
3,000 | $0 | 13,418 (Direct) |
View |
| 2024-08-12 Exercise |
2024-08-14 4:12 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
14,058 | $85 | 15,610 (Direct) |
View |
| 2024-08-12 Exercise |
2024-08-14 4:12 pm |
N/A 2029-02-28 |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
20,725 | $0 | 15,610 (Direct) |
View |
| 2024-08-12 Exercise |
2024-08-14 4:12 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
6,667 | $97.72 | 15,610 (Direct) |
View |
| 2024-06-24 Option Award |
2024-06-26 4:26 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
2,498 | $0 | 14,718 (Direct) |
View |
Ownership |
2024-03-28 4:17 pm |
N/A N/A |
ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research |
0 | $0 | 124,620 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 5:56 pm |
N/A 2034-02-21 |
Ovid Therapeutics Inc. | OVID | Fitzgerald Kevin Joseph Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 4:51 pm |
N/A 2033-02-22 |
Ovid Therapeutics Inc. | OVID | Fitzgerald Kevin Joseph Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-02-03 Option Award |
2022-02-04 8:49 pm |
N/A 2032-02-02 |
Ovid Therapeutics Inc. | OVID | Fitzgerald Kevin Joseph Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-10-06 Option Award |
2021-10-07 4:44 pm |
N/A 2031-10-05 |
Ovid Therapeutics Inc. | OVID | Fitzgerald Kevin Joseph Director |
30,000 | $0 | 30,000 (Direct) |
View |